In response to the current situation of regional medical and health hierarchical diagnosis and treatment services and the existing problems in the continuity of medical services, this article applies supply chain management methods, system collaboration theory, and service ecosystem concepts to treat medical consortia as an organic whole. Based on the quality and efficiency of disease management in the whole life cycle of patients with difficult, complex and severe diseases, a multi-level and multi-disciplinary medical service supply chain model of difficult, complex and severe disease medical consortium is constructed with four core elements: patient flow, service flow, technology flow and information flow. This article provides a certain reference for the implementation of regional hierarchical diagnosis and treatment and the formulation of relevant policies in China from the perspective of theoretical research.
With the continuous development of new drugs and immunotherapy, the survival period of patient with multiple myeloma (MM) is continuously prolonged, and the disease is becoming chronic. Due to the involvement of multiple systems and numerous complications, the daily nursing for MM faces significant challenges. The doctor-nurse-patient integration model and the whole life cycle health management model for daily nursing of MM are expected to reduce the social burden related to diseases, improve patients’ quality of life, and reduce medical costs. This article provides a review on three aspects of MM doctor-nurse-patient integration, whole life cycle health management, and daily health management involving multiple systems.
Objective To address the "three-low predicament" in China’s valvular heart disease (VHD) diagnosis and treatment system (low detection rate, low intervention rate, and low follow-up rate), and to propose and implement a whole life cycle management model for VHD considering the increasing burden of degenerative valvular disease in the context of an aging population. Methods Since 2020, West China Hospital of Sichuan University has established a management system encompassing "assessment-decision-intervention-follow-up", including: (1) a risk-stratified, tiered management pathway; (2) six core functions ("promotion, screening, prevention, diagnosis, treatment, and rehabilitation") coordinated by disease-specific managers; (3) an intelligent decision support information platform; and (4) a collaborative network of multidisciplinary teams and regional academic alliances. Results Between 2020 and 2024, a total of 583 874 echocardiographic screenings were completed, identifying 3 401 (7.1%) high-risk patients with aortic valve disease, 18 657 (38.8%) medium-risk patients, and 26 031 (54.1%) low-risk patients. A total of 2 417 patients were enrolled in whole life cycle management. Patient satisfaction scores increased year by year, from 73.89 before 2020 to 93.74 in 2024. The 1-year mortality rate in the transcatheter aortic valve replacement (TAVR) cohort decreased from 8.2% to 5.3% (P<0.01). Conclusion The VHD whole life cycle management model, through optimized processes and integrated resources, has achieved significant results in standardizing diagnosis and follow-up procedures, improving patient satisfaction and quality of life, and reducing mortality. It provides a scalable practical model for VHD management in China.